Skip to Content
Merck
CN

SML3086

Diclofenac

≥98% (HPLC), powder, COX inhibitor

Synonym(s):

2-(2,6-dichloranilino) phenylacetic acid, 2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C14H11Cl2NO2
CAS Number:
15307-86-5
Molecular Weight:
296.15
NACRES:
NA.77
UNSPSC Code:
12352200
MDL number:
MFCD00056694

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Diclofenac, ≥98% (HPLC)

InChI

1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)

SMILES string

ClC1=CC=CC(Cl)=C1NC2=CC=CC=C2CC(O)=O

InChI key

DCOPUUMXTXDBNB-UHFFFAOYSA-N

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

2-8°C

Quality Level

100

Related Categories

Biochem/physiol Actions

Diclofenac is an orally available, potent and selective nonsteroidal anti-inflammatory drug (NSAID). Diclofenac is used to treat pain and inflammatory diseases. It inhibits both cycloxygenase-1 (COX-1) and cycloxygenase-2 (COX-2).

signalword

Danger

Hazard Classifications

Acute Tox. 3 Oral - Aquatic Chronic 2 - Repr. 2 - STOT RE 1 Oral

target_organs

Gastrointestinal tract

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000479185
0000479187
0000479187
0000479185
0000453158

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Tomohiro Yoshida et al.
Bioorganic & medicinal chemistry, 20(19), 5705-5719 (2012-09-11)
Dipeptidyl peptidase IV (DPP-4) inhibition is suitable mechanism for once daily oral dosing regimen because of its low risk of hypoglycemia. We explored linked bicyclic heteroarylpiperazines substituted at the γ-position of the proline structure in the course of the investigation

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service